Synonym
IDOR-1117-1680; IDOR-11171680; IDOR1117-1680
IUPAC/Chemical Name
(5-chloro-2-(2H-1,2,3-triazol-2-yl)phenyl)(2-((2-methylbenzo[d]thiazol-6-yl)methyl)pyrazolidin-1-yl)methanone
InChi Key
ALSUHNRRMDFCPI-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H19ClN6OS/c1-14-25-18-5-3-15(11-20(18)30-14)13-26-9-2-10-27(26)21(29)17-12-16(22)4-6-19(17)28-23-7-8-24-28/h3-8,11-12H,2,9-10,13H2,1H3
SMILES Code
ClC1=CC(C(N2CCCN2CC3=CC(SC(C)=N4)=C4C=C3)=O)=C(C=C1)N5N=CC=N5
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
438.93
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
Surivet JP, Jacob EM, Kessler M, Kohl C, Vaillant C, Bezençon O, Bouis P, Busch L, Gauvin JC, Kiry M, Litou C, Masse F, Mathieu CA, Mirre A, Peters JU, Rager T, Rey M, Ruetsch R, Steiner MA. Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia. Bioorg Med Chem. 2025 May 1;122:118132. doi: 10.1016/j.bmc.2025.118132. Epub 2025 Feb 26. PMID: 40048842.
